Penthrox approved in Germany
5 April 2018
ASX Announcement
Penthrox approved in Germany
Medical Developments International Limited (ASX: MVP) is delighted to announce that Penthrox has been approved for sale in Germany.
MVP CEO, Mr. John Sharman said, “We are excited that the Marketing Authorisation for Germany has been received. Germany is one of the most important markets for MVP, as the country is seen by many as a leader in pain drugs and therefore their imprimatur is doubly important for us.
For the full release, please refer to the following link: ASX Announcement – Penthrox Approval in Germany